Departments of Medicine and Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461
| 1. | Anderson, S., J. R. David, and D. McMahon-Pratt. 1983. In vivo protection against Leishmania mexicana mediated by monoclonal antibodies. J. Immunol. 131:1616-1618.[Medline] |
| 2. | Bowden, R. A., S. M. Estein, M. S. Zygmunt, G. Dubray, and A. Cloeckaert. 2000. Identification of protective outer membrane antigens of Brucella ovis by passive immunization of mice with monoclonal antibodies. Microbes Infect. 2:481-488.[CrossRef][Medline] |
| 3. | Bretscher, P. A. 1992. An hypothesis to explain why cell-mediated immunity alone can contain infections by certain intracellular parasites and how immune class regulation of the response can be subverted. Immunol. Cell. Biol. 70:343-351. |
| 4. | Brieland, J. K., L. A. Heath, G. B. Huffnagle, D. G. Remick, M. S. McClain, M. C. Hurley, R. K. Kunkel, J. C. Fantone, and C. Engleberg. 1996. Humoral immunity and regulation of intrapulmonary growth of Legionella pneumophila in the immunocompetent host. J. Immunol. 157:5002-5008.[Abstract] |
| 5. | Briles, D. E., C. Forman, and M. Crain. 1992. Mouse antibody to phosphocholine can protect mice from infection with mouse-virulent human isolates of Streptococcus pneumoniae. Infect. Immun. 60:1957-1962.[Abstract/Free Full Text] |
| 6. | Casadevall, A. 1998. Antibody-mediated protection against intracellular pathogens. Trends Microbiol. 6:102-103.[CrossRef][Medline] |
| 7. | Casadevall, A., and M. D. Scharff. 1994. "Serum Therapy" revisited: Animal models of infection and the development of passive antibody therapy. Antimicrob. Agents Chemother. 38:1695-1702.[Free Full Text] |
| 8. | Collins, F. M. 1979. Cellular antimicrobial immunity. Crit. Rev. Microbiol 7:27-91. |
| 9. | Dromer, F., J. Charreire, A. Contrepois, C. Carbon, and P. Yeni. 1987. Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody. Infect. Immun. 55:749-752.[Abstract/Free Full Text] |
| 10. | Dromer, F., C. Perrone, J. Barge, J. L. Vilde, and P. Yeni. 1989. Role of IgG and complement component C5 in the initial course of experimental cryptococcosis. Clin. Exp. Immunol. 78:412-417.[Medline] |
| 11. | Edelson, B. T., P. Cossart, and E. R. Unanue. 1999. Cutting edge: paradigm revisited: antibody provides resistance to Listeria infection. J. Immunol. 163:4087-4090.[Abstract/Free Full Text] |
| 12. | Edelson, B. T., and E. R. Unanue. 2001. Intracellular antibody neutralizes Listeria growth. Immunity 14:503-512.[CrossRef][Medline] |
| 13. | Eisenstein, T. K., L. M. Millar, and B. M. Sultzer. 1984. Immunity to infection with Salmonella typhimurium: mouse strain differences in vaccine- and serum-mediated protection. J. Infect. Dis. 150:425-435.[Medline] |
| 14. | Eisenstein, T. K., R. Tamada, J. Meissler, A. Flesher, and H. C. Oels. 1984. Vaccination against Legionella pneumophila: serum antibody correlates with protection induced by heat-killed or acetone-killed cells against intraperitoneal but not aerosol infection in guinea pigs. Infect. Immun. 45:685-691.[Abstract/Free Full Text] |
| 15. | Elzer, P. H., R. H. Jacobason, S. M. Jones, K. H. Nielsen, J. T. Douglas, and A. J. Winter. 1994. Antibody-mediated protection against Brucella abortus in BALB/c mice at successive periods after infection: variation between virulent strain 2308 and attenuated vaccine strain 19. Immunology 82:651-658.[Medline] |
| 16. | Feldmesser, M., and A. Casadevall. 1997. Effect of serum IgG1 against murine pulmonary infection with Cryptococcus neoformans. J. Immunol. 158:790-799.[Abstract] |
| 17. | Fleuridor, R., Z. Zhong, and L. Pirofski. 1998. A human IgM monoclonal antibody prolongs survival of mice with lethal cryptococcosis. J. Infect. Dis. 178:1213-1216.[Medline] |
| 18. | Fulop, M., P. Mastroeni, M. Green, and R. W. Titball. 2001. Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis. Vaccine 19:4465-4472.[CrossRef][Medline] |
| 19. | Glatman-Freedman, A., and A. Casadevall. 1998. Serum therapy for tuberculosis revisited: a reappraisal of the role of antibody-mediated immunity against Mycobacterium tuberculosis. Clin. Microbiol. Rev. 11:514-532.[Abstract/Free Full Text] |
| 20. | Han, Y., and J. E. Cutler. 1995. Antibody response that protects against disseminated candidiasis. Infect. Immun. 63:2714-2719.[Abstract] |
| 21. | Joiner, K. A., R. Scales, K. A. Warren, M. M. Frank, and P. A. Rice. 1985. Mechanism of action of blocking immunoglobulin G for Neisseria gonorrhoeae. J. Clin. Investig. 76:1765-1772. |
| 22. | Kang, H., J. S. Remington, and Y. Suzuki. 2000. Decreased resistance of B-cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-gamma, TNF-alpha, and inducible nitric oxide synthase. J. Immunol. 164:2629-2634.[Abstract/Free Full Text] |
| 23. | Kaylor, P. S., T. B. Crawford, T. F. McElwain, and G. H. Palmer. 1991. Passive transfer of antibody to Ehrlichia risticii protects mice from ehrlichiosis. Infect. Immun. 59:2058-2062.[Abstract/Free Full Text] |
| 24. | Koesling, J., T. Aebischer, C. Falch, R. Schülein, and C. Dehio. 2001. Cutting Edge: Antibody-mediated cessation of hemotropic infection by the intraerythrocytic mouse pathogen Bartonella grahamii. J. Immunol. 167:11-14.[Abstract/Free Full Text] |
| 25. | Lee, E., and Y. Rikihisa. 1997. Anti-Ehrlichia chaffeensis antibody complexed with E. chaffeensis induces potent proinflammatory cytokine mRNA expression in human monocytes through sustained reduction of I B- and activation of NF- B. Infect. Immun. 2890:2897. |
| 26. | Li, J. S., F. Chu, A. Reilly, and G. M. Winslow. 2002. Antibodies highly effective in SCID mice during infection by the intracellular bacterium Ehrlichia chaffeensis are of picomolar affinity and exhibit preferential epitope and isotype utilization. J. Immunol. 169:1419-1425.[Abstract/Free Full Text] |
| 27. | Li, J. S., and G. M. Winslow. 2003. Survival, replication, and antibody susceptibility of Ehrlichia chaffeensis outside of host cells. Infect. Immun. 71:4229-4237.[Abstract/Free Full Text] |
| 28. | Mackaness, G. B. 1971. Resistance to intracellular infection. J. Infect. Dis. 123:439-445.[Medline] |
| 29. | Mackaness, G. B. 1977. Cellular immunity and the parasite. Adv. Exp. Med. Biol. 93:65-73.[Medline] |
| 30. | Messick, J. B., and Y. Rikihisa. 1994. Inhibition of binding, entry, or intracellular proliferation of Erhlichia risticii in P388D1 cells by anti-E. risticii serum, immunoglobulin G, or Fab fragment. Infect. Immun. 62:3156-3161.[Abstract/Free Full Text] |
| 31. | Mukherjee, J., G. Nussbaum, M. D. Scharff, and A. Casadevall. 1995. Protective and non-protective monoclonal antibodies to Cryptococcus neoformans originating from one B-cell. J. Exp. Med. 181:405-409.[Abstract/Free Full Text] |
| 32. | Mukherjee, J., M. D. Scharff, and A. Casadevall. 1992. Protective murine monoclonal antibodies to Cryptococcus neoformans. Infect. Immun. 60:4534-4541.[Abstract/Free Full Text] |
| 33. | Mukherjee, J., M. D. Scharff, and A. Casadevall. 1995. Variable efficacy of passive antibody administration against diverse Cryptococcus neoformans strains. Infect. Immun. 63:3353-3359.[Abstract] |
| 34. | Pal, S., I. Theodor, E. M. Peterson, and L. de la Maza. 1997. Monoclonal immunoglobulin A antibody the major outer membrane protein of the Chlamydia trachomatis mouse pneumonitis biovar protects mice against a chlamydial genital challenge. Vaccine 15:575-582.[CrossRef][Medline] |
| 35. | Parish, C. R. 1972. The relationship between humoral and cell-mediated immunity. Transplant. Rev. 13:35-66.[Medline] |
| 36. | Peterson, E. M., X. Cheng, V. L. Motin, and L. de la Maza. 1997. Effect of immunoglobulin G isotype on the infectivity of Chlamydia trachomatis in a mouse model of intravaginal infection. Infect. Immun. 65:2693-2699.[Abstract] |
| 37. | Pethe, K., S. Alonso, F. Biet, G. Delogu, M. J. Brennan, and F. D. Menozzi. 2001. The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination. Nature 412:190-194.[CrossRef][Medline] |
| 38. | Phalipon, A., M. Kaufmann, P. Michetti, J. Cavaillon, M. Huerre, P. Sansonetti, and J. Kraehenbuhl. 1995. Monoclonal immunoglobulin A antibody directed against serotype-specific epitope of Shigella flexneri lipopolysaccharide protects against murine experimental shigellosis. J. Exp. Med. 182:769-778.[Abstract/Free Full Text] |
| 39. | Pirofski, L. 2001. Polysaccharides, mimotopes and vaccines for fungal and encapsulated pathogens. Trends Microbiol. 9:445-451.[CrossRef][Medline] |
| 40. | Sanford, J. E., D. M. Lupan, A. M. Schlagetter, and T. R. Kozel. 1990. Passive immunization against Cryptococcus neoformans with an isotype-switch family of monoclonal antibodies reactive with cryptococcal polysaccharide. Infect. Immun. 58:1919-1923.[Abstract/Free Full Text] |
| 41. | Sayles, P. C., G. W. Gibson, and L. L. Johnson. 2000. B cells are essential for vaccination-induced resistance to virulent Toxoplasma gondii. Infect. Immun. 68:1026-1033.[Abstract/Free Full Text] |
| 42. | Silverstein, A. M. 1979. History of immunology. Cellular versus humoral immunity: determinants and consequences of an epic 19th century battle. Cell. Immunol. 48:208-221.[CrossRef][Medline] |
| 43. | Taborda, C. P., and A. Casadevall. 2001. Immunoglobulin M efficacy against Cryptococcus neoformans: mechanism, dose dependence and prozone-like effects in passive protection experiments. J. Immunol. 66:2100-2107. |
| 44. | Taborda, C. P., J. Rivera, O. Zaragoza, and A. Casadevall. 2003. More is not necessarily better: prozone-like effects in passive immunization with immunoglobulin G. J. Immunol. 170:3621-3630.[Abstract/Free Full Text] |
| 45. | Teitelbaum, R., A. Glatman-Freedman, B. Chen, J. B. Robbins, E. R. Unanue, A. Casadevall, and B. R. Bloom. 1998. A monoclonal antibody recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival. Proc. Natl. Acad. Sci. USA 95:15688-15693.[Abstract/Free Full Text] |
| 46. | Usinger, W. R., and A. H. Lucas. 1999. Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides. Infect. Immun. 67:2366-2370.[Abstract/Free Full Text] |
| 47. | Winslow, G. M., E. Yager, K. Shilo, E. Volk, A. Reilly, and F. K. Chu. 2000. Antibody-mediated elimination of the obligate intracellular bacterial pathogen Erhlichia chaffeensis during active infection. Infect. Immun. 68:2187-2195.[Abstract/Free Full Text] |
| 48. | Yuan, R., A. Casadevall, J. Oh, and M. D. Scharff. 1997. T cells cooperate with passive antibody to modify Cryptococcus neoformans infection in mice. Proc. Natl. Acad. Sci. USA 94:2483-2488.[Abstract/Free Full Text] |
| 49. | Yuan, R., A. Casadevall, G. Spira, and M. D. Scharff. 1995. Isotype switching from IgG3 to IgG1 converts a non-protective murine antibody to C. neoformans into a protective antibody. J. Immunol. 154:1810-1816.[Abstract] |